Jeffrey M McKENNA

Title: Innovator Profile: Jeffrey M. McKenna

Introduction: Jeffrey M. McKenna is a distinguished inventor based in Basel, Switzerland. With a singular patent to his name, McKenna has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compound derivatives aimed at treating various diseases.

Latest Patents: McKenna holds a patent titled "Hydroquinazoline derivatives for the treatment of a disease or disorder." This patent details a compound of Formula (I) or a pharmaceutically acceptable salt thereof, wherein specific components are defined as described in the documentation. This innovation constitutes a notable advancement in therapeutic methods and compounds.

Career Highlights: In his professional journey, Jeffrey M. McKenna has established himself as a key figure in the research and development sector. Currently employed at Novartis AG, he plays an integral role in the formulation of new pharmacological treatments, highlighting his commitment to advancing medicinal science.

Collaborations: Throughout his career, McKenna has collaborated with esteemed colleagues, including Daniela Angst. This collaborative effort exemplifies the importance of teamwork in the innovation process within the pharmaceutical industry, fostering creativity and enhancing research outcomes.

Conclusion: Jeffrey M. McKenna's work exemplifies the spirit of innovation in modern medicine. His contributions, particularly through his patented inventions, underscore the vital role that inventors play in addressing health challenges. As research continues to evolve, McKenna remains a prominent figure in the ongoing pursuit of effective therapeutic solutions.